Parkin regulates translesion DNA synthesis in response to UV radiation
Metrics: PDF 927 views | HTML 1137 views | ?
Xuefei Zhu1,*, Xiaolu Ma2,*, Yingfeng Tu1,*, Min Huang2, Hongmei Liu1, Fengli Wang1, Juanjuan Gong1, Jiuqiang Wang1, Xiaoling Li1, Qian Chen1, Hongyan Shen2, Shu Zhu1, Yun Wang1, Yang Liu2, Caixia Guo2, Tie-Shan Tang1
1State Key Laboratory of Membrane Biology, Institute of Zoology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100101, China
2CAS Key Laboratory of Genomics and Precision Medicine, Beijing Institute of Genomics, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Beijing 100101, China
*These authors contributed equally to this work
Caixia Guo, email: email@example.com
Tie-Shan Tang, email: firstname.lastname@example.org
Keywords: Parkin, translesion DNA synthesis, ultraviolet radiation, melanoma, Parkinson’s disease
Received: January 23, 2017 Accepted: March 27, 2017 Published: April 05, 2017
Deficiency of Parkin is a major cause of early-onset Parkinson’s disease (PD). Notably, PD patients also exhibit a significantly higher risk in melanoma and other skin tumors, while the mechanism remains largely unknown. In this study, we show that depletion of Parkin causes compromised cell viability and genome stability after ultraviolet (UV) radiation. We demonstrate that Parkin promotes efficient Rad18-dependent proliferating cell nuclear antigen (PCNA) monoubiquitination by facilitating the formation of Replication protein A (RPA)-coated ssDNA upon UV radiation. Furthermore, Parkin is found to physically interact with NBS1 (Nijmegen breakage syndrome 1), and to be required for optimal recruitment of NBS1 and DNA polymerase eta (Polη) to UV-induced damage sites. Consequently, depletion of Parkin leads to increased UV-induced mutagenesis. These findings unveil an important role of Parkin in protecting genome stability through positively regulating translesion DNA synthesis (TLS) upon UV damage, providing a novel mechanistic link between Parkin deficiency and predisposition to skin cancers in PD patients.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.